The third quarter financial results of ACADIA Pharmaceuticals (NASDAQ: ACAD) will be revealed on Wednesday 6th November 2024. This eagerly awaited announcement is slated to occur after market close, enabling investors and market participants to gain valuable insights into the company's financial performance.
The latest projections from financial analysts on Wall Street suggest that the firm is likely to reveal an estimated $0.14 profit per share for the quarter. Additionally, the company is expected to announce revenueS of $248.81 million for the period.
The company's full-year performance has been analyzed by wall street analysts, who have shared their projections. According to the analysis, it is expected that the company will generate a total revenue of $952.48 million. Additionally, the earnings per share for the company are also anticipated to reach profit of $0.51 over the course of the fiscal year.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share loss of $0.4. This figure was a result of the company's total revenue, which reached an impressive $211.7 million million during that specific period.
ACAD has scheduled a conference call on 6th November 2024 at 04:30 PM eastern time to discuss the third quarter financial results and other related information.
ACADIA Pharmaceuticals (ACAD) experienced a trading range of $14.54 to $14.87, along with a total volume of 1.16 million shares during the day. The stock concluded Friday's regular trading session at $14.81, demonstrating a gain of 1.51 percent.
